Skip to main content
. 2023 Aug 8;13(4):924–943. doi: 10.3390/clinpract13040085

Figure 12.

Figure 12

(A,C) A 43-year-old prior to treatment; (B,D) 6 months post treatment, in which 1 mL crosslinked hyaluronic acid (HA) was injected in the deep subcutaneous plane in each malar and zygomatic area, combined with 5 mL guided SEFFI injected in the superficial subcutaneous plane in the same area in the same session.